Seize the Opportunity Underutilization of Fine-Needle Aspiration Biopsy to Inform Targeted Cancer Therapy Decisions

被引：56

作者：

Clark, Douglas P. ^{[1
,2
]}

机构：

[1] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA

[2] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA

来源：

CANCER CYTOPATHOLOGY | 2009年 / 117卷 / 05期

关键词：

CIRCULATING TUMOR-CELLS; GENE-EXPRESSION PROFILES; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; EGFR MUTATIONS; WORKING GROUP; COPY NUMBER; SPECIMENS; SURVIVAL; CHEMOTHERAPY;

D O I：

10.1002/cncy.20045

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：289 / 297

页数：9

共 43 条

[1]

Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner [J].

Akbari, M ;

Hansen, MD ;

Halgunset, J ;

Skorpen, F ;

Krokan, HE .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (01) :36-39

[2]

American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy [J].

Allegra, Carmen J. ;

Jessup, J. Milburn ;

Somerfield, Mark R. ;

Hamilton, Stanley R. ;

Hammond, Elizabeth H. ;

Hayes, Daniel F. ;

McAllister, Pamela K. ;

Morton, Roscoe F. ;

Schilsky, Richard L. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (12) :2091-2096

[3]

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[4]

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].

Bossuyt, PM ;

Reitsma, JB ;

Bruns, DE ;

Gatsonis, CA ;

Glasziou, PP ;

Irwig, LM ;

Lijmer, JG ;

Moher, D ;

Rennie, D ;

de Vet, HCW .

CLINICAL CHEMISTRY, 2003, 49 (01) :1-6

[5]

*CAP TECHN ASS COM, KRAS MUT TEST COL CA

[6]

Classification of human tumors using gene expression profiles obtained after microarray analysis of fine-needle aspiration biopsy samples [J].

Centeno, BA ;

Enkemann, SA ;

Coppola, D ;

Huntsman, S ;

Bloom, G ;

Yeatman, TJ .

CANCER CYTOPATHOLOGY, 2005, 105 (02) :101-109

[7]

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].

Cobleigh, MA ;

Vogel, CL ;

Tripathy, D ;

Robert, NJ ;

Scholl, S ;

Fehrenbacher, L ;

Wolter, JM ;

Paton, V ;

Shak, S ;

Lieberman, G ;

Slamon, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648

[8]

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer [J].

Cohen, Steven J. ;

Punt, Cornelis J. A. ;

Iannotti, Nicholas ;

Saidman, Bruce H. ;

Sabbath, Kert D. ;

Gabrail, Nashat Y. ;

Picus, Joel ;

Morse, Michael ;

Mitchell, Edith ;

Miller, M. Craig ;

Doyle, Gerald V. ;

Tissing, Henk ;

Terstappen, Leon W. M. M. ;

Meropol, Neal J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3213-3221

[9]

Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].

Cristofanilli, M ;

Budd, GT ;

Ellis, MJ ;

Stopeck, A ;

Matera, J ;

Miller, MC ;

Reuben, JM ;

Doyle, GV ;

Allard, WJ ;

Terstappen, LWMM ;

Hayes, DF .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791

[10]

*DAK, DAK HERC PACK INS

← 1 2 3 4 5 →